InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,330.00
(
0.34%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.90
(
0.56%
)
Bitcoin
61,382.37
(
-0.38%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Bob Stocks

Send PM Follow Ignore
Followers 330
Posts 14071
Boards Moderated 2
Alias Born 08/10/2005

Bob Stocks

Re: Bob Stocks post# 87517

Thursday, 04/23/2015 12:26:04 PM

Thursday, April 23, 2015 12:26:04 PM

Post# of 97239
AVXL data near or close to September....Epilepsy data in May...awaiting Orphan drug designation...Got this off the AVXL board

Alzheimer's Weekly names ANAVEX 2-73 the number one most promising trial drug in Alzheimer's disease and Anavex's Phase I clinical program as "Trial of the Year"

Out of tens of thousands, AVXL shines. Its about time the investment community took notice!


http://www.prnewswire.com/news-releases/alzheimers-weekly-names-anavex-2-73-the-number-one-most-promising-trial-drug-in-alzheimers-disease-and-anavexs-phase-i-clinical-program-as--trial-of-the-year-113003209.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up